The release of betamethasone 17-valerate from extemporaneous dilutions of a proprietary topical cream
Six different vehicles for topical use were used to prepare 50% dilutions of Betnovate@ (betamethasone 17-valerate, 0.1 %) cream. Blanching assessment was undertaken immediately after preparing the various dilutions and at 1 and 3 months thereafter. Few statistically significant differences were not...
Main Authors: | Magnus, A D, Haigh, J M, Kanfer, I |
---|---|
Format: | Others |
Language: | English |
Published: |
1981
|
Online Access: | http://hdl.handle.net/10962/d1006322 |
Similar Items
-
Assessment of some variables affecting the blanching activity of betamethasone 17-valerate cream
by: Magnus, A D, et al.
Published: (1980) -
Influence of the oil phase dispersion in a cream base on the in vivo release of betamethasone 17-valerate
by: Haigh, J M, et al.
Published: (1992) -
Comparative blanching activities of proprietary diflucortolone valerate topical preparations
by: Coleman, G L, et al.
Published: (1978) -
A stability-indicating HPLC assay with on-line clean-up for betamethasone 17-valerate in topical dosage forms
by: Smith, E W, et al.
Published: (1985) -
Comparative bioavailability of some locally manufactured betamethasone valerate containing preparations
by: Meyer, E, et al.
Published: (1983)